​

Atossa Therapeutics Ownership | Who Owns Atossa Therapeutics?


OverviewForecastFinancialsChart

Atossa Therapeutics Ownership Summary


Atossa Therapeutics is owned by 10.89% institutional investors, 1.85% insiders, and 87.26% retail investors. Blackrock is the largest institutional shareholder, holding 7.34% of ATOS shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 3.05% of its assets in Atossa Therapeutics shares.

ATOS Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockAtossa Therapeutics10.89%1.85%87.26%
SectorHealthcare Stocks 128.69%12.02%-40.72%
IndustryBiotech Stocks 180.58%11.62%-92.20%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock9.20M7.34%$10.94M
Vanguard group6.15M4.76%$3.63M
Vanguard capital management361.75K4.06%$705.41K
Blackrock funding, inc. /de168.62K1.89%$328.81K
Renaissance109.91K1.23%$214.32K
Geode capital management95.58K1.07%$186.42K
Vanguard fiduciary trust52.58K0.59%$102.54K
State street39.76K0.45%$77.53K
Ubs group30.51K0.34%$59.49K
Morgan stanley12.35K0.14%$24.07K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Point72 asia (singapore) pte.44.11K0.01%$38.24K
Greenberg financial group18.22K0.00%$10.75M
Planning capital management1.00K0.00%$1.19K
Renaissance109.91K0.00%$214.32K
Northrock partners16.75K0.00%$14.52K
Blackrock9.20M0.00%$10.94M
Jain global16.71K0.00%$14.48K
Unique wealth strategies166.000.00%$299.00
Vanguard group6.15M0.00%$3.63M
Nbh bank69.000.00%$135.00

Top Buyers

HolderShares% AssetsChange
Blackrock9.20M0.00%6.45M
Vanguard group6.15M0.00%68.99K
Bank of america corp /de/105.67K-25.74K
Greenberg financial group18.22K0.00%18.22K
Blackrock funding, inc. /de168.62K-4.26K

Top Sellers

HolderShares% AssetsChange
Ameriprise financial---3.79M
Laurion capital management lp---2.23M
Millennium management---1.24M
Jacobs levy equity management---1.05M
Citadel advisors---648.12K

New Positions

HolderShares% AssetsChangeValue
Greenberg financial group18.22K0.00%18.22K$10.75M
Barclays2.56K-2.56K$4.99K
Planning capital management1.00K0.00%1.00K$1.19K
Unique wealth strategies166.000.00%166.00$299.00
Bfc planning124.00-124.00$242.00

Sold Out

HolderChange
Eversource wealth advisors-2.00
Larson financial group-20.00
Capital performance advisors llp-25.00
True wealth design-29.00
Srs capital advisors-42.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 202632-3.03%970,464-34.90%103.89%157.14%6-33.33%
Jun 30, 202633-2.94%1,490,79620.23%168.09%1455.56%9-64.00%
Mar 31, 202632-52.24%1,239,476-94.35%144.98%9-71.88%23155.56%
Dec 31, 202518-74.29%6,781,735-65.01%52.33%7-65.00%2-92.00%
Sep 30, 202520-76.74%6,698,329-68.63%51.90%6-85.00%3-88.00%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard US Total Market Shares ETF3.94M3.05%-
Vanguard Total Stock Mkt Idx Inv256.14K2.57%-
Vanguard Morn Total Stk Mkt Idx Investor256.14K2.57%-
Vanguard MStar Total Stk Mkt Idx Invest256.14K2.57%-
iShares Russell 2000 ETF3.15M2.44%-
Columbia Small Cap Value Discovery Fund194.83K1.95%5.60K
Columbia Small Cap Value I A2.09M1.62%57.50K
Columbia Small Cap Value I2.04M1.58%2.04M
Fidelity Small Cap Index1.29M1.00%-
Vanguard Institutional Extnd Mkt Idx Tr99.07K0.99%-

Recent Insider Transactions


DateNameRoleActivityValue
May 21, 2025QUAY STEVEN C President & CEOBuy$9.89K
Mar 26, 2025Remmel H. Lawrence-Buy$7.00K
Apr 10, 2024Finn Jonathan-Buy$44.25K
Nov 15, 2023WEAVER GREGORY L Former EVP, CFO, & DirectorSell$32.50K
Jun 20, 2023WEAVER GREGORY L EVP & CFOBuy$48.50K

Insider Transactions Trends


DateBuySell
2026 Q2--
2026 Q1--
2025 Q4--
2025 Q21-
2025 Q11-

ATOS Ownership FAQ


Who Owns Atossa Therapeutics?

Atossa Therapeutics shareholders are primarily institutional investors at 10.89%, followed by 1.85% insiders and 87.26% retail investors. The average institutional ownership in Atossa Therapeutics's industry, Biotech Stocks , is 180.58%, which Atossa Therapeutics falls below.

Who owns the most shares of Atossa Therapeutics?

Atossa Therapeutics’s largest shareholders are Blackrock (9.2M shares, 7.34%), Vanguard group (6.15M shares, 4.76%), and Vanguard capital management (361.75K shares, 4.06%). Together, they hold 16.16% of Atossa Therapeutics’s total shares outstanding.

Does Blackrock own Atossa Therapeutics?

Yes, BlackRock owns 7.34% of Atossa Therapeutics, totaling 9.2M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 10.94M$. In the last quarter, BlackRock increased its holdings by 6.45M shares, a 234.28% change.

Who is Atossa Therapeutics’s biggest shareholder by percentage of total assets invested?

Point72 asia (singapore) pte is Atossa Therapeutics’s biggest shareholder by percentage of total assets invested, with 0.01% of its assets in 44.11K Atossa Therapeutics shares, valued at 38.24K$.

Who is the top mutual fund holder of Atossa Therapeutics shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of Atossa Therapeutics shares, with 3.05% of its total shares outstanding invested in 3.94M Atossa Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools